Screener
Halozyme Therapeutics HALO Foreign currency translation adjustment
Foreign currency translation adjustment at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept halo:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax.
The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001159036-26-000104
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Net income | $229,913 | $165,160 | $379,962 | $283,255 |
| Other comprehensive income | ||||
| Unrealized (loss) gain on marketable securities, net | (73) | (35) | (76) | 154 |
| Foreign currency translation adjustment | (29) | (3) | 16 | (3) |
| Unrealized gain (loss) on derivative instruments, net | 4,161 | (27,047) | 8,183 | (34,270) |
| Realized loss on derivative instruments, net | 814 | 2,095 | 2,138 | 1,887 |
| Comprehensive income | $234,786 | $140,170 | $390,223 | $251,023 |
Item 1. Financial Statements
FAQ
- What is Halozyme Therapeutics's foreign currency translation adjustment?
- Halozyme Therapeutics (HALO) reported foreign currency translation adjustment of -$29K in Q2 2026.
- How has Halozyme Therapeutics's foreign currency translation adjustment changed year-over-year?
- Halozyme Therapeutics's foreign currency translation adjustment decreased by 866.7% year-over-year, from -$3K to -$29K.
- What does foreign currency translation adjustment mean?
- Foreign currency translation adjustment as reported by Halozyme Therapeutics, Inc..
Ask your AI about Halozyme Therapeutics's foreign currency translation adjustment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude